Sources
1. Benjamin J, et al. Inositol treatment in psychiatry. Psychopharmacol Bull 1995; 31 (1): 167-175.
2. Levine J, et al. Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder. Am J Psychiatry 1995; 152:792-794.
3. Balderer G, Borbely AA. Effect of valerian on human sleep. Psychopharmacol 1985; 87:406-9.
4. Leathwood PD, et al. Aqueous extract of valerian root (Valeriana officinalis L.) improves sleep quality in man. Pharmacol Biochem Behav 1982; 17:65-71.
5. Lindahl O, Lindwall L. Double blind study of a valerian preparation. Pharmacol Biochem Behav 1989; 32(4):1065-6.
6. Krystal JH, Sanacora G, et al. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry. 2002;7 Suppl 1:S71-80.
7. Sanacora G et al. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry. Jul2004;61(7):705-13.
8. Kinzler E et al. Clinical efficacy of a kava extract in patients with anxiety syndrome: double-blind placebo controlled study over 4 weeks. Arzneim Forsch 1991;41:548-8.
9. Warnecke G. [Psychosomatic dysfunctions in the female climacteric. Clinical effectiveness and tolerance of Kava Extract WS 1490] Fortschr Med. 1991 Feb 10;109(4):119-22.
10. Hansel R, et al. Sedative-hypnotic compounds i the exhalation of hops, II. Z Naturforsch (C) Dec1980;35(11-12):1096-97.
11. Balch James F. and Phyllis A., Prescription for Nutritional Healing, 3rd ed., New York, NY: Penguin Putnam Avery, 2000: 3.
12. Facchinetti F et al. Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol Aug 1991;78(2):177-81.
13. Mauskop A et al. Role of magnesium in the pathogenesis and treatment of migraines. Clin Neurosci 1998;5(1):24-7.
14. Balch James F. and Phyllis A., Prescription for Nutritional Healing, 3rd ed., New York, NY: Penguin Putnam Avery, 2000: 15.
15. Bourin M et al. A combination of plant extracts in the treatment of outpatients with adjustment disorder with anxious mood: controlled study versus placebo. Fundam Clin Pharmacol 1997;11(2):127-32.
16. Benton D et al. The impact of long-term vitamin supplementation on cognitive functioning. Psychopharmacol 1995;117:298-305.
17. Kahn RS et al. L-5-hydroxytryptophan in the treatment of anxiety disorders. J Affect Disord Mar1985;8(2):1970-200
18. van Praag H et al. Depression vlunerability and 5-hydroxytryptophan prophylaxis. Psychiatry Res Sep1980;3(1):75-83.
19. Poldinger W et al. Functional-dimensional approach to depression: serotonin deficiency as a target syndrome in a comparison of 5-hydroxytryptophan and fluvoxamine. Psychopathology. 1991;24(2):53-81.